D.h.e. 45 Related Published Studies
Well-designed clinical trials related to D.h.e. 45 (Dihydroergotamine)
Assessing acute systemic effects of an inhaled drug with serial echocardiography:
a placebo-controlled comparison of inhaled and intravenous dihydroergotamine. [2013]
Effects of a supratherapeutic dose of investigational orally inhaled
dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active-
and placebo-controlled crossover study in healthy volunteers. [2012]
The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. [2004]
Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. [2001.11]
Haemodynamic effects of three doses of dihydroergotamine during spinal anaesthesia. [2001.09]
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data. [2001.07]
Effects of dihydroergotamine on intracranial pressure, cerebral blood flow, and cerebral metabolism in patients undergoing craniotomy for brain tumors. [2001.07]
A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. [2000.06]
Bioavailability of intranasal formulations of dihydroergotamine. [1999.11]
Dihydroergotamine nasal spray in the treatment of acute migraine. [1998.09]
Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. [1998.08]
Oral dihydroergotamine for therapy-resistant migraine attacks in children. [1997.02]
A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. [1996.08]
Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis. [1996.07]
A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. [1996.02]
A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. [1996.02]
The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination. [1996]
[Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks] [1995.11]
Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. [1995.05]
Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins. [1994.10]
Dihydroergotamine nasal spray for the acute treatment of migraine. [1994.03]
[Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo] [1993.11.15]
Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble. [1993.09]
Effect of dihydroergotamine on leg blood flow during combined epidural and general anaesthesia and postoperative deep vein thrombosis after cholecystectomy. [1993.04]
Lipolytic effect of low-molecular-weight-heparin (Fragmin) and heparin/dihydroergotamine in thromboprophylactic doses during total hip replacement. [1992.11]
Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results. [1992.09.07]
Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine. [1992.09]
Dihydroergokryptine versus dihydroergotamine in migraine prophylaxis: a double-blind clinical trial. [1991.07]
A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium/dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery. [1991.06]
Pharmacokinetic investigation of oral and i.v. dihydroergotamine in healthy subjects. [1991]
[Flunarizine and dihydroergotamine in the treatment of migraine in children] [1990.03]
Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis. [1989.04]
Effects of dihydroergotamine on psychomotor function, neuroendocrine parameters and blood pressure, in healthy volunteers. [1989.01]
Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine. [1989]
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery. [1988.07]
Dihydroergotamine and the thromboprophylactic effect of dextran 70 in emergency hip surgery. [1988.04]
[Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures] [1988.02]
Well-designed clinical trials possibly related to D.h.e. 45 (Dihydroergotamine)
Reduced efficacy of sumatriptan in migraine with aura vs without aura. [2015]
Sumatriptan (subcutaneous route of administration) for acute migraine attacks in
adults. [2012]
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and
without allodynia. [2012]
A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. [2009.06]
Symptomatic treatment of migraine in children: a systematic review of medication trials. [2005.08]
Randomized clinical trials of neurally mediated syncope. [2003.09]
Incidence and time course of cardiovascular side effects during spinal anesthesia after prophylactic administration of intravenous fluids or vasoconstrictors. [1998.08]
[Treatment of acute attack of migraine with sumatriptan] [1997.11]
[Treatment of acute migraine attacks] [1995.01]
[Increased wound healing disorders in patients with inguinal hernia caused by administration of antithrombotic agents in the abdominal wall] [1994.08]
Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients. [1994.07]
Current emergency treatment of severe migraine headaches. [1993.11]
[Ropivacaine 1% versus bupivacaine 0.75% without a vasoconstrictor. A comparative study of epidural anesthesia in orthopedic surgery] [1993.09]
Prevention of postoperative thromboembolism in gynaecological malignancy. [1993]
A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. [1992.08.01]
Cardiovascular parameters and catecholamines in volunteers during passive orthostasis. Influence of antihypotensive drugs. [1992.05]
[Propofol for sedation during postoperative mechanical ventilation. A comparative study with Lytic Mixture] [1992]
Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. [1992]
[Quality requirements in clinical studies in surgery exemplified by prevention of thromboembolism] [1991]
[Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement] [1991]
A comparative trial of three agents in the treatment of acute migraine headache. [1990.10]
Superficial hand and foot veins show no difference in sensitivity to constrictor agents. [1990.07]
[Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE] [1990.06]
[Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications] [1990]
Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. [1989.08]
A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery. [1989]
[Prevention of thromboembolism in hysterectomies with low molecular weight heparin Fragmin] [1988.03]
Other research related to D.h.e. 45 (Dihydroergotamine)
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments. [2011.10]
Where is dihydroergotamine mesylate in the changing landscape of migraine therapy? [2010.12]
Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine. [2010.05]
Dihydroergotamine: role in the treatment of migraine. [2009.09]
Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. [2009.01]
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. [2008.08]
Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog. [2008.07]
Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler. [2008.03]
Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial. [2007.06]
Contractile responses to ergotamine and dihydroergotamine in the perfused middle cerebral artery of rat. [2007.04]
Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review. [2007.04]
Repetitive dihydroergotamine nasal spray for treatment of refractory headaches: an open-label pilot study. [2006.10]
Other possibly related research studies
The Relative Efficacy of Meperidine for the Treatment of Acute Migraine: A Meta-analysis of Randomized Controlled Trials. [2008.07.14]
Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics. [2008.07]
Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo. [2008.07]
Treatment of children with migraine in the emergency department: a qualitative systematic review. [2008.05]
Triptans: actions and reactions. [2008.04]
Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes. [2008.01]
Acute treatment of paediatric migraine: A meta-analysis of efficacy. [2008.01]
Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment. [2007.08]
Emergency department management of acute migraine in children in Canada: a practice variation study. [2007.05]
Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats. [2007.04.24]
Acute treatment for migraine headache. [2007.02]
DHE in the pharmacotherapy of migraine: potential for a larger role. [2006.11]
Nasal delivery of antimigraine drugs: clinical rationale and evidence base. [2006.11]
Central sensitization theory of migraine: clinical implications. [2006.11]
Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii. [2006.06]
Diagnosis and treatment of cluster headache. [2006.04]
Acute therapy for migraine headaches. [2006.04]
Medications for migraine prophylaxis. [2006.01.01]
Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. [2008.06]
Migraine, allodynia, and implications for treatment. [2008.12]
The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. [2008.12]
[Pathophysiology of migraine and clinical implications] [2008.10]
Pharmacological management of postoperative ileus. [2009.04]
Cluster attacks responsive to recreational cannabis and dronabinol. [2009.06]
Diagnosis and management of the primary headache disorders in the emergency department setting. [2009.02]
|
